Xenon Pharmaceuticals saw the highest growth of 79% in patent filings in January and 199% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 79% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Xenon Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Xenon Pharmaceuticals has been focused on protecting inventions in Australia(AU) with two publications in Q1 2024

The Australia(AU) Patent Office dominates the patent filings and grants with nearly 14% filings and 17% grants. The South Korea(KR), Morocco(MA), Australia(AU), and European Patent Office(EPO) patent Office are among the top ten patent offices where Xenon Pharmaceuticals is filings its patents. Among the top granted patent authorities, Xenon Pharmaceuticals has 17% of its grants in Australia(AU) and 17% in Croatia(HR).

GW Research and F. Hoffmann-La Roche could be the strongest competitors for Xenon Pharmaceuticals

In terms of grant share, Xenon Pharmaceuticals stands in tenth position among its competitors. GW Research and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.

Epilepsy related patents lead Xenon Pharmaceuticals portfolio

Xenon Pharmaceuticals has highest number of patents in epilepsy. For epilepsy, nearly 100% of patents were filed and 100% of patents were granted in Q1 2024.

For comprehensive analysis of Xenon Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.